Insider Transactions in Q4 2021 at Ngm Biopharmaceuticals Inc (NGM)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 29 2021	David J Woodhouse Chief Executive Officer	BUY Exercise of conversion of derivative security	Direct	17,654 +35.45%	$123,578 $7.92 P/Share
Dec 07 2021	Jin Long Chen Chief Scientific Officer	SELL Open market or private sale	Direct	15,000 -1.62%	$270,000 $18.6 P/Share
Dec 06 2021	Jin Long Chen Chief Scientific Officer	BUY Exercise of conversion of derivative security	Direct	69,444 +6.99%	$69,444 $1.44 P/Share
Dec 06 2021	Jin Long Chen Chief Scientific Officer	SELL Open market or private sale	Direct	15,000 -1.73%	$270,000 $18.21 P/Share
Nov 18 2021	David J Woodhouse Chief Executive Officer	SELL Open market or private sale	Direct	15,000 -100.0%	$300,000 $20.02 P/Share
Nov 18 2021	David J Woodhouse Chief Executive Officer	BUY Exercise of conversion of derivative security	Direct	15,000 +50.0%	$105,000 $7.54 P/Share
Nov 15 2021	Jin Long Chen Chief Scientific Officer	SELL Open market or private sale	Direct	30,000 -1.68%	$570,000 $19.72 P/Share
Oct 12 2021	Jin Long Chen Chief Scientific Officer	SELL Open market or private sale	Direct	15,000 -1.64%	$300,000 $20.14 P/Share
Oct 11 2021	Jin Long Chen Chief Scientific Officer	SELL Open market or private sale	Direct	15,000 -1.61%	$300,000 $20.41 P/Share
Oct 05 2021	Hsiao D Lieu Chief Medical Officer	SELL Open market or private sale	Direct	2,000 -100.0%	$44,000 $22.0 P/Share
Oct 05 2021	Hsiao D Lieu Chief Medical Officer	BUY Exercise of conversion of derivative security	Direct	2,000 +50.0%	$24,000 $12.06 P/Share

Receive a notification when an Institution or Guru buys or sells NGM shares.

Notify only if

Value

Get notified when an Ngm Biopharmaceuticals Inc insider buys or sells NGM shares.

Notify only if

Operation

Value

Type

Receive news related to NGM BIOPHARMACEUTICALS INC